Avanos Medical (NYSE: AVNS) director cashed out at $25 merger price
Rhea-AI Filing Summary
AVANOS MEDICAL director Franchini Indrani Lall reported dispositions tied to the company’s merger. On July 27, 2026, she disposed of 4,817 shares of common stock at $25.00 per share, with each share converted into a cash right under the merger terms. On the same date, 12,003 cash-settled restricted share units, each linked to one share of common stock, were canceled and converted into cash based on the same $25.00 merger consideration, less tax withholdings. Following these transactions, the reported holdings for these securities are 0 shares/units.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,817 shares
Net Sell
2 txns
Insider
Franchini Indrani Lall
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Restricted Share Units F2, F3 | 12,003 | $25.00 | $300K |
| Disposition | Common Stock F1 | 4,817 | $25.00 | $120K |
Holdings After Transaction:
Restricted Share Units — 0 shares (Direct);
Common Stock — 0 shares (Direct)
Footnotes (3)
- F1. Pursuant to the Agreement and Plan of Merger, dated as of April 13, 2026 (as it has been or may be amended, supplemented, waived or otherwise modified in accordance with its terms, the Merger Agreement), by and among the Issuer, A-AV Holdco I, Inc., a Delaware corporation, and A-AV MergerSub, Inc. (Parent), a Delaware corporation and a wholly-owned subsidiary of Parent, each share of the Issuer's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the effective time of the merger (the Merger), which occurred on July 27, 2026, was converted into and exchanged for the right to receive $25.00 per share in cash, without interest (the Merger Consideration), payable in accordance with the terms and subject to the conditions of the Merger Agreement.
- F2. Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock.
- F3. Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings).
Key Figures
Common shares disposed: 4,817 shares
Cash-settled RSUs canceled: 12,003 units
Merger consideration per share: $25.00 per share
+2 more
5 metrics
Common shares disposed
4,817 shares
Common stock converted to cash at $25.00 per share on July 27, 2026
Cash-settled RSUs canceled
12,003 units
Restricted share units canceled and cash-settled at $25.00 per underlying share
Merger consideration per share
$25.00 per share
Cash paid for each share of Avanos common stock at merger effective time
Reported holdings after transactions
0.0000 shares/units
Post-transaction balances for the reported common stock and RSUs
Merger effective date
July 27, 2026
Date the merger closed and securities were converted to cash rights
Key Terms
Agreement and Plan of Merger, Merger Consideration, restricted share units, Effective Time of the Merger
4 terms
Agreement and Plan of Merger regulatory
"Pursuant to the Agreement and Plan of Merger, dated as of April 13, 2026"
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
Merger Consideration financial
"was converted into and exchanged for the right to receive $25.00 per share in cash, without interest (the Merger Consideration)"
Merger consideration is the total payment a company or buyer offers to shareholders of a target company in exchange for combining the two businesses, and can include cash, shares in the surviving company, debt assumption, or a mix of these. Investors care because the form and amount affect the deal’s value, tax consequences, immediate cash received versus future ownership, and the risk and upside of holding new shares — similar to choosing between cash now or stock that could grow later.
Effective Time of the Merger regulatory
"canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash"
The effective time of the merger is the exact moment when a planned combination of two companies legally takes effect, usually specified in the merger agreement and reflected by the formal filing or timestamp. For investors, it is the point when ownership, voting rights, financial reporting and control shift—like a light switch flipping that joins two rooms into one—so it determines when shares convert, who controls corporate decisions and which results appear in financial statements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Franchini Indrani Lall report for AVNS?
Franchini Indrani Lall reported dispositions related to Avanos Medical’s merger, including common stock and cash-settled restricted share units converted into cash at $25.00 per share as of July 27, 2026 under the merger terms.
What were the key merger terms affecting AVNS common stock in this report?
Each share of Avanos Medical common stock outstanding immediately before the merger’s effective time was converted into the right to receive $25.00 per share in cash, without interest, payable according to the conditions of the Agreement and Plan of Merger.
Does Franchini Indrani Lall retain any reported AVNS holdings after these transactions?
For the securities reported here, post-transaction balances show 0.0000 shares or units following the July 27, 2026 merger-related dispositions and cancellations, indicating no remaining reported holdings of these particular common shares and restricted share units.
Was a Rule 10b5-1 trading plan indicated for the AVNS insider transactions?
The Rule 10b5-1 trading plan checkbox was not marked as affirmative. The dispositions instead reflect treatment of the director’s AVNS common stock and cash-settled restricted share units under the Agreement and Plan of Merger at a $25.00 cash consideration.